Sandoz Memantine Fct 10 mg

Sandoz Memantine FCT 10 mg tablets contain memantine hydrochloride, a medication used to manage moderate to severe Alzheimer's disease symptoms. This oral tablet is manufactured by Sandoz Canada Incorporated and is available in a pack of 30.

Memantine hydrochloride is primarily used to manage symptoms of moderate to severe Alzheimer's disease. It works by regulating glutamate activity in the brain, which may help improve cognitive function, memory, and daily functioning. This medication is often prescribed as part of a comprehensive treatment plan for Alzheimer's disease.

Common effects of memantine hydrochloride may include dizziness, headache, and constipation. Some users might experience confusion or fatigue. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Memantine hydrochloride should be used with caution in individuals with a history of seizures, kidney problems, or liver disease. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Always store the tablets in a cool, dry place away from direct sunlight.

Memantine hydrochloride may interact with other medications, including certain antidepressants, antipsychotics, and drugs that affect kidney function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited while taking this medication.